NCT03551977

Brief Summary

Background: Research evidence shows that prevalence of pain in adolescents is increasing and is therefore recognized as a growing health problem. Psychological interventions delivered remotely through the internet may reduce intensity or severity of pain among children and adolescents with chronic pain. The iCanCope with Pain program is an existing web- and mobile-based self-management program, which is developed as a multi-center study funded by the Canadian Institutes of Health Research and is based on identified health care needs and current best practices for pain self-management. Objectives: The primary objectives are to describe the translation and cultural adaptation of the Norwegian version of the iCanCope with Pain mobile application and evaluate the effect in an upcoming randomized controlled trail with adolescents with chronic pain. Study sample: 16-19-year-old adolescents with self-declared persistent and/or chronic pain. Recruited from high schools in Southern Norway. Theoretical framework: Cognitive behavioral therapy (CBT) is explained by an integration of behavioral and cognitive theories of human behavior and psychopathology and is often the preferred treatment of choice for adolescents with different health disorders. The theoretical framework of CBT is integrated in the iCanCope with Pain app in terms of five components. The intervention group will receive the app with all five components: (I) symptom trackers for pain, sleep, mood, physical, and social function; (II) goal setting to improve pain and function; (III) coping toolbox of pain self-management strategies; (IV) social support; (V) age-appropriate pain education. The control group will receive the app with only the first self-registration component (I) symptom trackers for pain, sleep, mood, physical, and social function. Methods: Both qualitative and quantitative data will be gathered for evaluating the Norwegian version of the iCanCope with Pain app. Usability testing are assessed in both laboratory settings and in field using observation, interviews and questionnaires, which provide necessary information for an upcoming randomized controlled trail (RCT). Outcomes will in the RCT be measured at baseline (mid-April) and after an 8 weeks intervention (mid-June). The study is part of a PhD project.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 28, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 15, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 11, 2018

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2018

Completed
Last Updated

November 8, 2022

Status Verified

November 1, 2022

Enrollment Period

7 months

First QC Date

May 15, 2018

Last Update Submit

November 4, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Attrition rate

    Change in participants completed the post-questionnaire divided by the number of participants at baseline.

    Baseline and 8-weeks

  • App engagement

    Completion of daily symptom check-ins was used as a proxy for app engagement.

    Baseline to 8 weeks.

Secondary Outcomes (10)

  • Physical activity

    Baseline and 8 weeks (post-intervention)

  • Coping

    Baseline and 8 weeks (post-intervention)

  • Social participation

    Baseline and 8 weeks (post-intervention)

  • Over-The-Counter (OTC) analgesics

    Baseline and 8 weeks (post-intervention)

  • Perceived social support from friends

    Baseline and 8 weeks (post-intervention)

  • +5 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group will receive the iCanCope with Pain app with all five components: (I) symptom trackers for pain, sleep, mood, physical, and social function; (II) goal setting to improve pain and function; (III) coping toolbox of pain self-management strategies; (IV) social support; (V) age-appropriate pain education

Behavioral: iCanCope with Pain

Control group

ACTIVE COMPARATOR

The control group will receive the iCanCope with Pain control app with only the first self-registration component (I) symptom trackers for pain, sleep, mood, physical, and social function.

Behavioral: iCanCope with Pain control

Interventions

The participants are free to use the Norwegian iCanCope with Pain app as much as they want during the 8 week intervention period. The only support available is technical support.

Intervention group

The participants are free to use the Norwegian iCanCope with Pain control app as much as they want during the 8 week intervention period. The only support available is technical support.

Control group

Eligibility Criteria

Age16 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • year-old adolescents
  • with persistent and/or chronic pain, weekly suffered and lasting 3 months or more based on subjective reporting
  • be able to read and understand Norwegian
  • have their own smartphone.

You may not qualify if:

  • Adolescents with cognitive disability or diseases, because of the risk of not correctly understanding the iCanCope with Pain program via self-report, goal setting and/or library reading.
  • Adolescents that have participated in the usability testing of the Norwegian iCanCope with Pain app
  • Adolescents with diagnoses from a pathological or medical origin (e.g hematology/oncology patients) will also be excluded because the program was not specifically designed for these pain groups.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erik Grasaas

Kristiansand, 4633, Norway

Location

Related Publications (2)

  • Grasaas E, Helseth S, Fegran L, Stinson J, Smastuen M, Lalloo C, Haraldstad K. App-based intervention among adolescents with persistent pain: a pilot feasibility randomized controlled trial. Pilot Feasibility Stud. 2022 Jul 27;8(1):158. doi: 10.1186/s40814-022-01113-0.

  • Grasaas E, Helseth S, Fegran L, Stinson J, Smastuen M, Haraldstad K. Health-related quality of life in adolescents with persistent pain and the mediating role of self-efficacy: a cross-sectional study. Health Qual Life Outcomes. 2020 Jan 30;18(1):19. doi: 10.1186/s12955-020-1273-z.

MeSH Terms

Conditions

Pain

Interventions

Analgesia

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia and Analgesia

Study Officials

  • Kristin Haraldstad, PhD

    UiA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A single-centre, RCT study design with two arms, one control group (N=56) and one intervention group (N=56).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 15, 2018

First Posted

June 11, 2018

Study Start

November 28, 2017

Primary Completion

June 15, 2018

Study Completion

June 15, 2018

Last Updated

November 8, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations